Black men most likely to benefit from advanced prostate cancer therapies are 11 percent less likely to get them than non-Black men. This happens despite apparent equal opportunities in obtaining health care services, a new study in American veterans shows.
UToledo research shows the centriole's role in sperm evolved from a shock absorber to a transmission system
Os Laboratórios da Mayo Clinic divulgaram um teste autoimune inédito para o anticorpo da proteína 11 do tipo Kelch, ou KLHL11, usado para detectar uma doença autoimune associada ao câncer testicular. O teste está disponível nacional e internacionalmente.
Los Laboratorios de Mayo Clinic pusieron en marcha la primera prueba autoinmunitaria en su clase para el anticuerpo contra la proteína tipo Kelch 11 (KLHL11), que sirve para detectar una enfermedad autoinmunitaria relacionada con el cáncer de testículo. La prueba está disponible a nivel nacional e internacional.
Researchers report that about a quarter of localized prostate cancers may demonstrate immunologic traits that suggest a substantial number of patients with prostate cancer may benefit from immunotherapies.
New research finds elite athletes have temporary mitochondrial impairment after intense workouts, suggesting they may need to be mindful about overtraining. The study is published ahead of print in the Journal of Applied Physiology.
A new sports program is kicking goals for men’s health as researchers from the University of South Australia set their sights on improving physical and mental wellbeing of Australian men.
This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.
While postpartum depression in new mothers is well recognized and known to increase if the newborn requires intensive care, depression in new fathers has not received much attention. A large study, published in the journal Pediatrics, found that both parents with a baby in the NICU are at risk, with depression symptoms identified in 33 percent of mothers and 17 percent of fathers. Strikingly, the probability of reporting depression symptoms declined significantly for mothers but not for fathers after the baby came home.
The Pfizer and Moderna mRNA COVID-19 vaccines is safe for male reproduction, according to a new study by University of Miami Miller School of Medicine researchers published in JAMA , the most widely circulated general medical journal in the world.
Mayo Clinic Laboratories has launched a first-of-its-kind autoimmune test for the Kelch-like protein 11 antibody, or KLHL11, which is used to detect autoimmune disease associated with testicular cancer. The test is available nationally and internationally.
Don’t let dad wait for his “check engine” light to come on. This Father’s Day, encourage him to go to the doctor.
Researchers at Michigan Medicine found people with cerebral palsy have fragile bones that present high fracture risk, but at different times across the lifespan compared to the general population. The results helped them develop new sex-specific critical periods of bone health for this population.
Research from the University of Georgia has identified a protein that appears to prevent the cancer from spreading to and colonizing the bone, providing a new target for future therapeutics.
Men who suffer sensory loss, particularly hearing loss, are more likely to be physically inactive and obese than women, according to a new study published in the European Journal of Public Health.
New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC).
In a sample of nearly 500 young adults ranging in age from 18 to 25, researchers saw a reduction in problematic drinking and alcohol consequences during the initial phase of the pandemic for both men and women. This is in contrast to many anecdotal reports of increased drinking and increased household spending on alcohol during that time period. Additional findings showed increased rates of depression and anxiety symptoms among young women – increases that were not observed to a significant degree among male participants.
A new type of penile traction therapy (PTT) device can increase penile length and preserve erectile function in men who have undergone prostate cancer surgery (prostatectomy), reports a clinical trial in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Researchers from UTHealth and Arizona State University have teamed up on the first study looking at sex-targeted drug delivery for traumatic brain injuries in a five-year, $2.5 million project funded by the National Institutes of Health.
CLEVELAND: According to new findings published in Science Translational Medicine, Cleveland Clinic researchers have identified a promising drug target for treating and preventing aggressive, drug-resistant prostate cancer. The team, led by Nima Sharifi, M.D., of Cleveland Clinic’s Lerner Research Institute, demonstrated that inhibiting the protein H6PD led to significantly reduced tumor sizes and improved survival among mouse models with drug-resistant prostate cancer. The H6PD levels also were elevated in biopsied patient tumors, suggesting the protein might be targeted in patients for treatment.
University Hospitals offers a new technique called PrecisionPoint Transperineal Access System for obtaining a prostate biopsy. The hospital will also conduct a clinical trial to determine if it offers greater benefits than a traditional biopsy.
Lewis Palmer follows up with his UTHealth neurologist regularly to make sure he continues to get stronger and lower his risk of ever having a second stroke.
Screening and testing for sexually transmitted infections (STIs) decreased by 63% for men and 59% for women during the early months of the COVID-19 pandemic, according to a new study led by Penn State and Quest Diagnostics researchers.
A new study from Washington University School of Medicine in St. Louis suggests that, among men, low testosterone levels in the blood are linked to more severe COVID-19. The study contradicts widespread assumptions that higher testosterone may explain why men, on average, develop more severe COVID-19 than women do.
If there’s one take-home message for the general public about the coronavirus vaccines approved in the U.S., it’s that they are remarkably effective. But Michigan State University’s Morteza Mahmoudi is raising awareness about an important subtlety: The vaccines developed by Moderna and Pfizer-BioNTech appear to work slightly better for men than for women.
Environmental quality is associated with advanced-stage prostate cancer at diagnosis, according to a new study by University of Illinois Chicago researchers. Prostate cancer is up to 57% heritable, with the remainder attributed to environmental exposures. However, studies on those environmental factors and prostate cancer aggressiveness have previously been limited.
Is that raspy voice a sign of seasonal allergies, or could it be something else? Speech language pathologist Carrie Ruggiero explains the causes of hoarseness – and the health conditions it might be masking.
Though obesity in midlife is linked to an increased risk for Alzheimer’s disease, new research suggests that a high body mass index later in life doesn’t necessarily translate to greater chances of developing the brain disease.
Dr. Rachel Issaka, a gastroenterologist and assistant professor with UW Medicine, talks about the significance of the new recommendation and what it may mean for the Black community.
University of Miami Miller School of Medicine researchers report the widespread blood vessel dysfunction, or endothelial dysfunction, that results from the COVID-19 infection could contribute to erectile dysfunction, or ED, according to a study published in the World Journal of Men’s Health .
UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors - a type of protein specific to men - may destroy cancer cells. Focusing on this male protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer in men.
A recent study by the University of Eastern Finland shows that loneliness among middle-aged men is associated with an increased risk of cancer.
Just 16% of men 18 to 21 years old have received at least one dose of the HPV vaccine at any age. Yet oropharyngeal cancer, which occurs in the throat, tonsils, and back of the tongue, is now the leading cancer caused by HPV — and 80% of those diagnosed with it are men.
DALLAS – April 22, 2021 – Being Black or Hispanic, living in high-poverty neighborhoods, and having Medicaid or no insurance coverage are associated with higher mortality in men and women under 40 with cancer, a review by UT Southwestern Medical Center researchers found.
Henry Ford Cancer Institute has received a $250,000 grant from Pfizer Global Medical Grants and the American Cancer Society to reduce prostate cancer disparities among Black men. While all men are at risk for prostate cancer, Black men are at an increased risk for developing and dying from prostate cancer.
Consuming a diet high in pro-inflammatory foods – including foods that contain refined carbohydrates and sugar as well as polyunsaturated fats – may be associated with increased odds of developing testosterone deficiency among men, suggests a study in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Researchers at Albert Einstein College of Medicine have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer. The drug was tested in rats, and the findings were published online today in JCI Insight.
A new, urine-based test for aggressive prostate cancer being developed at the University of Michigan uses next-generation sequencing to assess 15 biomarkers to find cancer that can be missed by biopsies or imaging tests.
Researchers have discovered a new way to transform the tissues surrounding prostate tumors to help the body's immune cells fight the cancer. The discovery, made in human and mouse cells and in laboratory mice, could lead to improvements in immunotherapy treatments for prostate cancer, the second most common cancer in men in the U.S.
Tumor gene profiling is a tool that can help patients with a cancer diagnosis make informed decisions about treatment. In predominantly white populations, among men with early stage, favorable-risk prostate cancer, these tools have been shown to increase patient acceptance of active surveillance — a common, evidence-based approach to monitor the tumor before a more aggressive treatment, like surgery or radiation.
University Hospitals’ (UH) Irina Jaeger, MD, received the prestigious designation as a Center of Excellence for GreenLight™ Laser Therapy treatment – a minimally invasive outpatient procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms. Dr. Jaeger is a urologist at UH Richmond Medical Center and UH Brainard Medical Building in Lyndhurst. GreenLight Therapy can help provide immediate relief from enlarged prostate symptoms such as frequent urination—especially at night, weak urine flow, urgency and incomplete bladder emptying.
To highlight testicular cancer awareness month, an expert from Rutgers Cancer Institute of New Jersey addresses the basics of testicular cancer and the importance of self checks and talking to your doctor.
The findings published in eLife show that men with this unstable subtype of the Y chromosome have a significantly increased risk of genomic rearrangements.
Researchers at the University of Maryland School of Medicine (UMSOM) have been awarded $100,000 in funding through the Eugene Washington PCORI Engagement Awards, an initiative of the Patient-Centered Outcomes Research Institute (PCORI). The funds will support a national discussion and conference aimed at identifying evidence gaps to guide future research on the use of active surveillance to monitor low-risk prostate cancers. This serves as an alternative to immediate treatment with surgery, radiation or hormone therapy which all have potential debilitating side effects.
New genetic research suggests men can develop characteristics of polycystic ovary syndrome (PCOS)—a common metabolic and reproductive disorder that affects women. The study was presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right